Nasal administration of propranolol
AssigneeUniversity of Kentucky Research Foundation
InventorsAnwar A. Hussain, Shinichiro Hirai, Rima Bawarshi
Life of this patent
Estimating the term…
Abstract
The invention relates to a novel method of administering propranolol, a known .beta.-andrenergic blocking agent widely used in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further relates to novel dosage forms of propranolol which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.
Claims7
A method for eliciting a .beta.-andrenergic blocking response in a warm-blooded animal in need of such therapy, comprising nasally administering to said animal a therapeutically effective amount of a compound having the formula:
- ##STR2## or nontoxic pharmaceutically acceptable derivative thereof.
Dependencies are inferred from the claim text.